A New Oral CLL and SLL Treatment: What Could It Mean for Patients?

The Food and Drug Administration (FDA) recently approved idelalisib (Zydelig), a new oral inhibitor therapy to treat CLL and SLL. Patients now have another option that may spare them the need for chem... Author: patientpower Added: 08/03/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts